All data are based on the daily closing price as of October 16, 2026
s
Shinpoong Pharm
019170.KO
7.21 USD
0.40
+5.87%
Overview
Last close
7.21 usd
Market cap
372.99M usd
52 week high
12.95 usd
52 week low
5.04 usd
Target price
4.33 usd
Valuation
P/E
N/A
Forward P/E
17.7305
Price/Sales
2.1564
Price/Book Value
1.7992
Enterprise Value
366.65M usd
EV/Revenue
2.0411
EV/EBITDA
33.9897
Key financials
Revenue TTM
179.63M usd
Gross Profit TTM
76.72M usd
EBITDA TTM
10.53M usd
Earnings per Share
-0.02 usd
Dividend
N/A usd
Total assets
236.83M usd
Net debt
2.79M usd
About
Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.